Clinical Trials in Nashville

Showing 3681-3700 of 15,379 trials

The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults

NCT05824572

The objective of this study is to conduct a multisite trial evaluating the impact of adding an audio recording of clinic visits (AUDIO) to usual care in older adults with multimorbidity, including diabetes, compared to After Visit Summary (AVS) alone (Usual Care; UC).

Diabetes

Dartmouth-Hitchcock Medical Center336 participantsStarted Dec 2023

Manchester, New Hampshire, United States • Nashville, Tennessee, United States • Galveston, Texas, United States

TERMINATEDPhase 1< 1 mile

A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors

NCT05387265

The purpose of this first-in-human study, CTMX-904-101, is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-904 in adult subjects with metastatic or locally advanced unresectable solid tumors.

Solid Tumors

CytomX Therapeutics83 participantsStarted May 2022

Denver, Colorado, United States • Nashville, Tennessee, United States • Houston, Texas, United States +2 more locations

Active Not Recruiting< 1 mile

MitraClip EXPAND G4 Study

NCT04177394

This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.

Mitral Valve RegurgitationMitral Regurgitation

Abbott Medical Devices1,164 participantsStarted Jan 2020

Birmingham, Alabama, United States • Mobile, Alabama, United States • Little Rock, Arkansas, United States +60 more locations

The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults

A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors

MitraClip EXPAND G4 Study

Find Trials by Condition in Nashville

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

A Study of JNJ-55308942 in the Treatment of Bipolar Depression

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

The Life STORRIED Study

Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)

A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors